RenaissanceRe Holdings Ltd . (NYSE: NYSE:RNR) reported fourth quarter earnings that beat analyst expectations, while revenue fell short of estimates.

The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease ...

Tom Lee, Fundstrat Global Advisors managing partner and head of research, appeared on CNBC to talk about his 2025 playbook.

Shares of off-Road and powersports vehicle corporation Polaris (NYSE:PII) fell 8.3% in the morning session after the company ...

We recently published a list of 10 AI News And Ratings on Wall Street’s Radar. In this article, we are going to take a look ...

Shares of data warehouse-as-a-service Snowflake (NYSE:SNOW) jumped 7.3% in the morning session as the debate around the ...

Rubrik’s 38% YoY growth and momentum in cyber resilience offer solid prospects. Learn why RBRK stock is a buy with a $110 ...

These four passive income stocks are often overlooked by investors and are dividend wonders. They are rated Buy at top Wall ...

10:30 a.m. Atlanta Fed GDPNow fourth quarter update.

ATLANTA, Jan. 28, 2025 /PRNewswire/ -- Norfolk Southern Corporation (NYSE: NSC ) announced today a quarterly dividend of $1.35 per share on its common stock. The dividend is payable Feb. 20, 2025, to ...

The S&P500 and the Nasdaq Composite declined as investors questioned America's AI dominance after DeepSeek launched its free ...